Form 4: Quest Diagnostics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, sold 225 shares of common stock on February 28, 2024, to cover tax obligations arising from vesting restricted share units.
Summary
- Mark E. Delaney, SVP & Chief Commercial Officer of Quest Diagnostics, filed a Form 4 on March 1, 2024, reporting a transaction on February 28, 2024.
- Delaney sold 225 shares of Quest Diagnostics common stock at a price of $126.36 per share.
- The sale was to satisfy tax obligations related to the vesting of restricted share units.
- Following the transaction, Delaney directly owns 5,603 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an executive's stock sale for tax purposes, which is a neutral event.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock sale transaction. |
| 03/01/2024 | Date Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.